Artal Group S.A. - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,952
-100.0%
400,0000.0%0.11%
-55.7%
Q3 2022$5,768,000
-4.7%
400,0000.0%0.25%
-23.8%
Q2 2022$6,052,000
+27.4%
400,0000.0%0.32%
+62.3%
Q1 2022$4,752,000
-26.7%
400,0000.0%0.20%
+13.1%
Q4 2021$6,484,000
-43.2%
400,0000.0%0.18%
-31.0%
Q3 2021$11,416,000
-15.6%
400,0000.0%0.26%
-6.9%
Q2 2021$13,520,000
+11.8%
400,0000.0%0.27%
+28.0%
Q1 2021$12,096,000
-14.3%
400,000
+40.3%
0.21%
-29.4%
Q4 2020$14,112,000
+29.0%
285,0280.0%0.30%
+13.9%
Q3 2020$10,942,000
-15.6%
285,028
-5.0%
0.27%
-26.7%
Q2 2020$12,961,000
+24.1%
300,030
-25.0%
0.36%
-17.7%
Q1 2020$10,440,000
-16.5%
400,0000.0%0.44%
-8.7%
Q4 2019$12,500,000
+19.9%
400,0000.0%0.48%
+15.6%
Q3 2019$10,424,000
+13.9%
400,0000.0%0.42%
+13.0%
Q2 2019$9,148,000
+799.5%
400,000
+700.0%
0.37%
+873.7%
Q4 2018$1,017,000
-74.5%
50,000
-66.7%
0.04%
-63.5%
Q3 2018$3,984,000150,0000.10%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,271,0002.63%
Sofinnova Investments, Inc. 2,194,278$26,068,0001.98%
MPM BioImpact LLC 443,702$5,271,0001.42%
Soleus Capital Management, L.P. 238,982$2,839,0000.37%
Lombard Odier Asset Management (Switzerland) SA 221,774$2,635,0000.21%
Artal Group S.A. 400,000$4,752,0000.20%
Polar Capital Holdings Plc 2,877,671$34,187,0000.15%
ASHFORD CAPITAL MANAGEMENT INC 106,770$1,268,0000.14%
Cormorant Asset Management, LP 150,000$1,782,0000.14%
Virtus ETF Advisers LLC 23,646$281,0000.13%
View complete list of Y-MABS THERAPEUTICS INC shareholders